Attitudes about Testicular Self-Examination among Polish Males.
cancer prevention
polish males
testicular cancer
testicular self-examination
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
19 Mar 2021
19 Mar 2021
Historique:
received:
31
01
2021
revised:
13
03
2021
accepted:
16
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Epidemiological data indicate an increased incidence of testicular cancer (TC), making it the most common malignant tumor in men from aged 15-45. Oncological and urological associations recommend that men with specific TC risk factors should regularly perform a testicular self-exam (TSE). The aim of the study was to discover the attitudes among Polish males regarding TSE and factors (environmental, social, educational) that affect intention to perform TSE. An original survey containing 21 questions was used to conduct a study among the Polish branch of VW (Volkswagen Poland) employees. A total of 522 fully completed questionnaires were collected. The mean age of the surveyed respondents was 32 years. Information about TC and how to perform TSE was obtained by 34.4% ( Approximately half of young polish males do not perform TSE. Access to information on TC prevention is limited. Further action is needed to improve men's awareness of TC and TSE.
Identifiants
pubmed: 33808756
pii: biology10030239
doi: 10.3390/biology10030239
pmc: PMC8003475
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Public Health (Oxf). 2008 Mar;30(1):111-3
pubmed: 17981887
Wiad Lek. 2018;71(8):1456-1462
pubmed: 30684324
Am J Mens Health. 2018 May;12(3):531-538
pubmed: 26483292
Am J Mens Health. 2017 Mar;11(2):253-261
pubmed: 27645516
Am Fam Physician. 2018 Feb 15;97(4):261-268
pubmed: 29671528
Sci Rep. 2020 Nov 26;10(1):20684
pubmed: 33244121
J Cancer Educ. 2017 Mar;32(1):105-111
pubmed: 26358248
BMC Health Serv Res. 2008 Jul 03;8:141
pubmed: 18598339
Ir J Med Sci. 2020 Aug;189(3):811-815
pubmed: 31838732
Int J Cancer. 2005 Sep 1;116(3):331-9
pubmed: 15818625
Eur Urol. 2015 Dec;68(6):1054-68
pubmed: 26297604
Am J Mens Health. 2015 Nov;9(6):506-18
pubmed: 25359870
Urology. 2020 May;139:64-70
pubmed: 32001306
Curr Opin Genet Dev. 2010 Jun;20(3):225-30
pubmed: 20303738
Int J Nurs Stud. 2017 Feb;67:41-50
pubmed: 27915088
Medicine (Baltimore). 2018 Sep;97(37):e12390
pubmed: 30213007
J Cancer Educ. 2016 Jun;31(2):236-43
pubmed: 25649663
Papillomavirus Res. 2018 Jun;5:21-31
pubmed: 29248818
Asian Pac J Cancer Prev. 2015;16(11):4741-3
pubmed: 26107234
Adv Urol. 2018 Feb 18;2018:8671832
pubmed: 29670654
Nat Rev Urol. 2012 Apr 17;9(6):339-49
pubmed: 22508459
Am J Mens Health. 2018 Sep;12(5):1510-1516
pubmed: 29717912
Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1151-9
pubmed: 20447912
Nat Rev Dis Primers. 2018 Oct 5;4(1):29
pubmed: 30291251
J Cancer Educ. 2018 Apr;33(2):398-403
pubmed: 27815814
Cancer. 2006 Mar 1;106(5):1169-77
pubmed: 16421921
Curr Urol. 2020 Jun;14(2):92-97
pubmed: 32774234
J Health Commun. 2014;19(3):303-20
pubmed: 24117344